Cardiology; Patient Care

Implementing Cardiovascular Genomics Symposium
CME (AMA PRA Category 1 Credits™) 3.5; Attendance CEU 3.5

Wednesday, October 11
8:00 AM - 12:00 PM

The goal of this session is to highlight the implementation of Cardiovascular Genomics in the various clinics through Mayo Clinic and their integration into the CV genomics program.

7-8.00 Continental Breakfast
8:00 am Welcome and Introduction to the Mayo Cardiovascular Genomics Program: Iftikhar Kullo, MD
8:30 am The Cardiac Channelopathies: Who Needs an ICD? Michael J. Ackerman, MD, PhD from the Long QT Syndrome/Genetic Heart Rhythm Clinic
9:00 am Hypertrophic Cardiomyopathy: Who Needs Intervention/ICD: Steve Ommen, MD from the HCM Clinic
9:30 am Aortopathy Genotype and When to Cut: Juan Bowen, MD and David Deyle, MD from the Marfan/Aortopathy Clinic
10:00 am Break
10:20 am Recent Genetic Insights into Dilated Cardiomyopathy: Naveen Pereira, MD from the DCM Clinic
10:50 am Genetic Implications of Familial Hypercholesterolemia: Iftikhar Kullo, MD from the Familial Hypercholesterolemia Clinic
11:20 am Bringing it all together: Panel Discussion: Speakers, Katherine Agre, CGC; Teresa Kruisselbrink, CGC
12:00 pm Adjourn


Learning Objectives:

Iftikhar Kullo

Professor
Cardiovascular Diseases, Mayo Clinic

Iftikhar Kullo, MD, completed medical school training in Kashmir, India, followed by residency (internal medicine) and fellowship (cardiovascular diseases) training at Mayo Clinic in Rochester, Minn., where he is currently a consultant in the Division of Cardiovascular Diseases and a professor of medicine at the Mayo Clinic College of Medicine.

His clinical areas of interest include peripheral arterial disease, uncommon arteriopathies, and aortic aneurysm and dissection syndromes. He directs the Early Atherosclerosis and Cardiovascular Genomics Clinics at Mayo Clinic in Rochester.

Dr. Kullo's research focus is on translational cardiovascular genetics. His work encompasses both discovery of novel genetic variants influencing disease susceptibility and drug response as well as implementation of genomics using the electronic health record.

Dr. Kullo is the principal investigator, with Stephen Thibodeau PhD, of the Mayo electronic medical records and genomics (eMERGE) grant. He is also the lead investigator of the Myocardial Infarction Genes (MI-GENES) study, a randomized clinical trial of communicating genomic information to individuals at intermediate risk of coronary heart disease. Dr. Kullo is a member of the NIH's Clinical and Integrative Cardiovascular Sciences Study Section (CICS) Study Section.

Presentation(s):

Send Email for Iftikhar Kullo

Mike Ackerman

Mayo Clinic

Michael Ackerman, MD, of Mayo Clinic in Rochester, Minn., is the Windland Smith Rice Cardiovascular Genomics Research Professor and a professor of medicine, pediatrics and pharmacology at Mayo Clinic College of Medicine.

As director of Mayo Clinic's Long QT Syndrome/Genetic Heart Rhythm Clinic and the Windland Smith Rice Sudden Death Genomics Laboratory, Dr. Ackerman strives to fulfill the twofold objective of medical education and biomedical research as stated by Dr. Charles H. Mayo: "to heal the sick and to advance the science."

He has published more than 400 articles and chapters across the continuum of basic, translational and clinical research with a focus on cardiac channelopathies, hypertrophic cardiomyopathy and sudden cardiac death in the young.

Dr. Ackerman received his M.D. and Ph.D. from Mayo Medical School and Mayo Graduate School and completed pediatric and pediatric cardiology training at Mayo School of Graduate Medical Education. Dr. Ackerman is president of the Sudden Arrhythmia Death Syndromes (SADS) Foundation.

Presentation(s):

Send Email for Mike Ackerman

David Deyle

Assistant Professor
Mayo Clinic

Presentation(s):

Send Email for David Deyle

Naveen Pereira

Professor of Medicine and Associate Professor of Pharmacology
Mayo Clinic

Naveen L. Pereira, MD, is a Consultant for the Division of Cardiovascular Diseases and Assistant Professor of Medicine and Pharmacology, Mayo Clinic College of Medicine. He is board certified in internal medicine, cardiovascular diseases and advanced heart failure and transplant. Dr. Pereira earned his medical degree at University of Bombay. He completed his internship and residency at the University of Connecticut and cardiac fellowship at the Brown University Hospital System and Massachusetts General Hospital. Dr. Pereira has received many awards including the Mayo Clinic Department of Medicine Career Development Award, Marie Ingalls Cardiovascular Career Development Award, Academic Research in Cardiology Award, Transplant Center Scholarly Program Award, and Clinical Immunology and Immunotherapeutic Program Award. He was the recipient of the Clinical and Translational Sciences KL2 Award with a focus on translating the genetics of pharmacotherapy. He was the chairperson of the Standards and Guidelines Workforce of the International Society of Heart and Lung Transplantation. He is a member of the Functional Genomics and Translational Biology Council of the American Heart Association and on the editorial board of Circulation: Cardiovascular Genetics. Dr. Pereira's research interests include treatment of endstage heart failure, antibody-mediated rejection in heart transplant, cardiac allograft hypertrophy, genetics of the natriuretic peptide system and pharmacogenomics.

Presentation(s):

Send Email for Naveen Pereira

Steve R. Ommen

Professor of Medicine
Mayo Clinic

Presentation(s):

Send Email for Steve Ommen

Teresa Kruisselbrink

Supervisory Genetic Counselor
Mayo Clinic Center for Individualized Medicine

Teresa Kruisselbrink is Genetic Counselor Supervisor in the Mayo Clinic Center for Individualized Medicine. She began her career in 1997 at Mayo Clinic by establishing the role of the laboratory based genetic counselor in Molecular Genetics, Biochemical Genetics, Cytogenetics and Maternal Serum Screening. She has provided genetic counseling in Medical Genetics, neurology, obstetrics, cardiology and outreach clinics. Ms. Kruisselbrink contributes to numerous educational programs including Mayo Medical School, Graduate School, and fellowship and residency programs in the laboratory and clinical environments. She is also actively involved in mentoring high school and college students wishing to pursue a career in genetic counseling. Teresa received her B.S. in Molecular, Cellular, Developmental Biology and Genetics and M.S. in Genetic Counseling from the University of Minnesota. She is an Instructor of Laboratory Medicine and Pathology.

Presentation(s):

Send Email for Teresa Kruisselbrink

Katherine Agre

Genetic Counselor
Center for Individualized Medicine, Mayo Clinic

Katherine (Katie) Agre, MS, CGC, of Mayo Clinic in Rochester, Minnesota, is a genetic counselor in the Department of Clinical Genomics. Katie received her B.S. in Biology and M.S. in Genetic Counseling from the University of Minnesota. She began her career at Mayo Clinic in June 2016. She has provided genetic counseling services in various indications including cancer, cardiology, general, and diagnostic odyssey patients. Her clinical interest lies within cardiology where she sees indications such as amyloidosis, cardiomyopathy, arrhythmia, familial hypercholesterolemia, and others. She is also the primary counselor in the Marfan Clinic where she sees patients due to personal and/or family history of aortopathy. Katie is also actively involved in research projects and enjoys her work in mentoring and supervising students interested in the field of genetic counseling. In addition to her work at Mayo Clinic, Katie is an active member of the National Society for Genetic Counselors. She is a Co-Chair for the Familial Hypercholesterolemia Working Group and an active member of the Membership Committee and Amyloidosis Working Group.

Presentation(s):

Send Email for Katherine Agre


Assets

Implementing Cardiovascular Genomics Symposium
CME (AMA PRA Category 1 Credits™) 3.5; Attendance CEU 3.5



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Implementing Cardiovascular Genomics Symposium
CME (AMA PRA Category 1 Credits™) 3.5; Attendance CEU 3.5